RNA编辑介导COPA功能转换在肝细胞癌发生新机制中的作用
研究在125例肝细胞癌(HCC)患者队列中分析COPA编辑的临床意义,并用CRISPR/Cas9敲除编辑位点互补序列(ECS)以删除内源性编辑的COPA转录本。研究发现ADAR2结合COPA前体mRNA第6外显子与第6内含子ECS形成的双链RNA,导致第164位异亮氨酸变为缬氨酸;COPA编辑减少参与HCC发病,编辑后COPAWT由促瘤基因转为抑瘤基因并具有显性负效应,COPAI164V可能通过下调小窝蛋白-1(CAV1)失活PI3K/AKT/mTOR通路。
要点
- ADAR2结合COPA前体mRNA第6外显子与第6内含子ECS形成的双链RNA,导致第164位异亮氨酸变为缬氨酸。
- COPA编辑减少参与HCC发病,并可能涉及多种癌症类型。
- 编辑后COPAWT由促瘤基因转为抑瘤基因并具有显性负效应,COPAI164V可能通过下调CAV1失活PI3K/AKT/mTOR通路。
核心结论
- 研究揭示一种RNA编辑相关的肝癌发生机制:ADAR2下调导致肿瘤中抑瘤性COPAI164V丢失并同时积累促瘤性COPAWT;COPAI164V蛋白快速降解和PI3K/AKT/mTOR通路过度激活进一步促进肿瘤发生。
研究设计与样本
- 在125例HCC患者队列中研究COPA编辑的临床意义。
- 采用CRISPR/Cas9介导敲除编辑位点互补序列(ECS)以删除内源性编辑的COPA转录本。
- 在放线菌素D或环己酰亚胺处理下研究COPA编辑介导的转录本或蛋白稳定性变化。
- 在细胞模型和小鼠中研究野生型与编辑型COPA(COPAWT vs COPAI164V)在肿瘤发生中的功能差异及确切机制。
主要发现
- ADAR2结合COPA前体mRNA第6外显子与第6内含子ECS形成的双链RNA,导致第164位异亮氨酸变为缬氨酸。
- COPA编辑减少参与HCC发病,并可能涉及多种癌症类型。
- 编辑后COPAWT由促瘤基因转为抑瘤基因,具有显性负效应。
- COPAI164V可能发生蛋白构象改变,因此比COPAWT更不稳定。
- COPAI164V可能通过下调小窝蛋白-1(CAV1)失活PI3K/AKT/mTOR通路。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: RNA editing introduces nucleotide changes in RNA sequences. Recent studies have reported that aberrant adenosine-to-inosine RNA editing is implicated in cancers. Until now, very few functionally important protein-recoding editing targets have been discovered. Here, we investigated the role of a recently discovered protein-recoding editing target COPA (coatomer subunit α) in hepatocellular carcinoma (HCC). METHODS: Clinical implication of COPA editing was studied in a cohort of 125 HCC patients. CRISPR/Cas9-mediated knockout of the editing site complementary sequence (ECS) was used to delete edited COPA transcripts endogenously. COPA editing-mediated change in its transcript or protein stability was investigated upon actinomycin D or cycloheximide treatment, respectively. Functional difference in tumourigenesis between wild-type and edited COPA (COPAWTvs. COPAI164V) and the exact mechanisms were also studied in cell models and mice. RESULTS: ADAR2 binds to double-stranded RNA formed between edited exon 6 and the ECS at intron 6 of COPA pre-mRNA, causing an isoleucine-to-valine substitution at residue 164. Reduced editing of COPA is implicated in the pathogenesis of HCC, and more importantly, it may be involved in many cancer types. Upon editing, COPAWT switches from a tumour-promoting gene to a tumour suppressor that has a dominant-negative effect. Moreover, COPAI164V may undergo protein conformational change and therefore become less stable than COPAWT. Mechanistically, COPAI164V may deactivate the PI3K/AKT/mTOR pathway through downregulation of caveolin-1 (CAV1). CONCLUSIONS: We uncover an RNA editing-associated mechanism of hepatocarcinogenesis by which downregulation of ADAR2 caused the loss of tumour suppressive COPAI164V and concurrent accumulation of tumour-promoting COPAWT in tumours; a rapid degradation of COPAI164V protein and hyper-activation of the PI3K/AKT/mTOR pathway further promote tumourigenesis. LAY SUMMARY: RNA editing is a process in which RNA is changed after it is made from DNA, resulting in an altered gene product. In this study, we found that RNA editing of a gene known as coatomer subunit α (COPA) is lower in tumour samples and discovered that this editing process changes COPA protein from a tumour-promoting form to a tumour-suppressive form. Loss of the edited COPA promotes the development of liver cancer.
引用
- Song Y, An O, Ren X, et al. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis. J Hepatol. 2020. PMID: 32693003. doi:10.1016/j.jhep.2020.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。